Signia IX Delivers More Than Twice the Speech Enhancement Benefit in Noisy Group Conversations Than Closest Competitors

New study reveals that Signia Integrated Xperience (IX) outperforms the competition with a 3.2 dB higher signal-to noise ratio compared to the very best of its top 4 competitor hearing aids. This means that Signia IX delivers more than twice the speech enhancement benefit in a noisy group conversation than the closest competitors, including AI co-processor-driven platforms. Lynge, Denmark – October 14, 2024 – At a time when hearing family and friends in noise continues to be the top requirement for hearing aid wearers,[1] hearing aid innovator Signia announced today the results of a new study that demonstrates the superiority of its Signia Integrated Xperience (IX) platform to overcome the added challenge of following dynamic group conversations in noisy environments. [2] According to study results, Signia IX, with its Real Time Conversation Enhancement (RTCE) technology, substantially outperformed other leading hearing aids in measured output SNR with at least a 3.2 dB higher conversation signal-to-noise ratio (SNR) in a group conversation set-up. The current study pits Signia IX against the latest technology from competing hearing aid manufacturers – including those with AI co-processor-driven platforms – employing a method that simulates a typical group conversation in background noise. Jens Moeller, Head of Brand, Signia, said: Integrated Xperience is about more than just hearing better. It is about giving hearing aid wearers the confidence to engage, interact, and contribute – especially in noisy group conversations. Only Signia Integrated Xperience hearing aids independently enhance speech and process noise so wearers can better follow dynamic group conversations. To prove that point, we’ve studied the signal-to-noise ratios of leading hearing aids in a realistic dynamic group conversation scenario – and the results clearly show Signia IX is still the leader. The boost in conversation SNR, achieved through Signia IX’s unique split and multi-stream processing technology, significantly enhances conversation performance for Signia IX hearing aid wearers in dynamic group conversations. Conversation Performance Tests in Dynamic Group Conversations Despite advances in noise reduction by different manufacturers, including products featuring machine learning and artificial intelligence, other platforms still employ single-stream processing, where speech and noise are processed in the same way. This approach to processing limits their ability to improve SNR under dynamic conditions. However, Signia IX overcomes this limitation by managing speech and noise separately in a multi-stream architecture. “Signia IX’s unique multi-stream platform requires studies with multiple speakers in order to showcase and confirm its performance in group conversations,” Moeller continued. “We believe these multi-speaker test setups are crucial for advancing the industry beyond simple comparisons with static single speakers in noise.” The latest lab tests analyzed the performance of Signia IX and key competitors’ hearing aids using a KEMAR manikin and four independent loudspeakers, positioned in front and behind the manikin. Two loudspeakers simulated background noise, while the other two played sections of the International Speech Test Signal (ISTS) at intervals to simulate conversation partners entering and leaving a group conversation from different locations. Signia IX hearing aids showed an 8.1 dB improvement in conversation SNR compared to unaided listening. The nearest competitor showed only a 4.9 dB improvement. Details are now available in a new Signia white paper establishing a real-world methodology for testing conversation SNR. “As this rigorous study shows, Signia Integrated Xperience offers the best improvement in overall conversation SNR, which means wearers can better engage with multiple family members and friends regardless of background noise,” Moeller concluded. “Signia’s goal is always to help people connect with conversations, and when it comes to studying the results of our engineering, Signia is committed to evaluating hearing aids in conditions that matter to wearers in everyday life.” To read a detailed account of Signia’s new lab study, click here. For more information on Signia, click here. [1] “Consumer Ratings of the Most Desirable Hearing Aid Attributes,” Manchaiah et al., 2021 [2] Jensen NS, Wilson C, Kamkar Parsi H, Samra B, Hain J, Best S & Taylor B. 2024. Signia IX delivers more than twice the speech enhancement benefit in a noisy group conversation than the closest competitors. Signia White Paper. Retrieved from www.signia-library.com. About Signia Signia is one of the world’s leading hearing aid brands. We aim to enhance human performance through iconic innovations and consumer-friendly designs that shape the hearing health market. Since its launch in 2016, Signia has regularly brought innovative, industry-leading solutions to the market and is a pioneer in rechargeable hearing technology. In addition to highly innovative hearing aids, Signia also delivers tools and apps to increase customer interaction and engagement at all levels of hearing aid management. Signia, and its hearing care professionals, enable hearing aid wearers not just to correct hearing loss but to gain an edge — to Be Brilliant.
Subscribe to releases from WS Audiology
Subscribe to all the latest releases from WS Audiology by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from WS Audiology
Carsten Buhl to leave WSA10.6.2025 00:00:00 CEST | Press release
Lynge, Denmark, June 10, 2025 – WSA, a leading pure-play hearing healthcare group, today announced that Carsten Buhl, member of the Executive Committee and Executive Board of WSA, and President of its Americas Region, has decided to pursue a new career outside WSA and to leave the company on August 31, 2025. Carsten Buhl joined WSA in 2019, where he first served as President of the EMEA-LATAM-Canada region, next to being a member of WSA’s Group Management Team. In 2022 he was appointed President of the Americas Region. WSA CEO Jan Makela commented: We are sorry to see Carsten go and will certainly miss his constructive leadership style, as well as his deep insights into the hearing care market. We are happy for him as we part ways on positive terms. We are grateful for his many contributions to our company, and we wish him every success! Carsten Buhl said: “I am proud of my journey at WSA and what we have achieved together working with a fantastic group of highly motivated colleagues.
Dorothea Wenzel joins WSA’s Board of Directors and is appointed Chair of the Audit Committee2.6.2025 00:00:00 CEST | Press release
Lynge, Denmark, June 2, 2025 – WSA, a leading pure-play hearing healthcare group, is pleased to announce that Dorothea Wenzel has joined its Board of Directors and has been appointed Chair of the Audit Committee, effective immediately. At the same time, Julian Tøpholm is stepping down from the Board. Ms. Wenzel joins as an independent director with an impressive track record in finance and strategy leadership across multiple industries, including a long career at the biopharmaceutical company Merck, where she held several commercial and financial executive positions. She has extensive experience in leading business transformations, and significant board experience from Dentsply Sirona Inc., Servier Group, Gerresheimer, and as Lead Independent Director at Fresenius Medical Care AG & Co. Most recently, she was appointed Chair of Lundbeck, following her tenure as Chair of its Audit Committee. WSA Chair Lars Rasmussen commented: We are delighted to welcome Dorothea to the WSA Board. Her br
WSA delivered 1% organic revenue growth and increased EBITDA by 22% in the second quarter of FY 2024/258.5.2025 00:00:00 CEST | Press release
Lynge, Denmark – May 8, 2025 – WSA, a leading pure-play hearing healthcare group, today announced results for the second quarter of the financial year 2024/25 (January 1, 2025 – March 31, 2025) showing organic revenue growth of 1% and an increase in EBITDA of 22%, corresponding to an EBITDA margin improvement of 2.8%-points. Jan Mäkelä, CEO of WSA, said: With an organic revenue growth of 1% in a volatile macro environment and a significant EBITDA margin improvement, WSA delivered satisfactory second quarter results. I am very pleased with the successful launch of Signia BCT IX and Widex Allure at the end of the quarter. With our complementary and distinct Signia and Widex brand platforms, we are committed to delivering an uncompromising hearing experience that meets the unique needs of the largest groups of people with hearing loss and the hearing care professionals serving them.” Highlights Q2 2024/2025 (Q2 last financial year in brackets) WSA delivered organic revenue growth of 1% (7
WS Audiology Expands Indian Operations with New Commercial and Production Hub in Bangalore16.4.2025 00:00:00 CEST | Press release
Bangalore, India – 16 April 2025 – WS Audiology (WSA), a leading pure play hearing health care group, today announced the opening of its new office in Bangalore, further strengthening its footprint in India. The facility, operating as WS Audiology India, will serve as a key hub for commercial and production activities, supporting WSA’s long-term commitment to improve hearing health access across the country. The new Bangalore office reflects WSA’s belief in India’s growing role in the global hearing care landscape. According to the World Health Organization, an estimated 6.3% of India’s population suffers from significant hearing loss. WSA continues to lead the industry in making hearing care more accessible, affordable, and effective through its “Triple A” approach—Awareness, Affordability, and Accessibility. Supporting Growth, Enhancing Service “India has been one of our fastest-growing markets in APAC, and we’re incredibly proud of the work our teams have done here,” said Avinash Pa
WSA welcomes ATHOS KG as a new shareholder and receives new investment to support its long-term development11.4.2025 00:00:00 CEST | Press release
Lynge, Denmark – 11 April 2025 – WS Audiology (WSA), a leading pure play hearing health care group, today announced ATHOS KG as a new minority shareholder, as well as an equity capital injection of EUR c. 590 million in total from its existing and new shareholders to further support the company’s successful growth trajectory and long-term strategic ambitions. WSA welcomes ATHOS, a German healthcare focused single family office, as a new shareholder alongside T&W Medical, EQT, and the Lundbeck Foundation, which together continue to exercise joint control of WSA in an unchanged governance set-up. Lars Rasmussen, Chair of WSA, said: I am pleased by the strong commitment of WSA’s shareholders to the company’s continued growth and long-term development. The owners have decided to strengthen WSA’s financial foundation by injecting equity, which will further bring down WSA’s net leverage. At the same time, I am pleased to welcome ATHOS as a shareholder of WSA. With T&W Medical, EQT, the Lundb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom